Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients
Clinical trial NCT02790580 · UNKNOWN
Trial details
- NCT number
- NCT02790580
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-05-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.